• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)
LI Shun-Hua, LI Lin, YANG Ru-Nan, LIANG Shang-Dong. Compounds of traditional Chinese medicine and neuropathic pain [J]. Chin J Nat Med, 2020, 18(1): 28-35.. doi: 10.1016/S1875-5364(20)30002-9
Citation: LI Shun-Hua, LI Lin, YANG Ru-Nan, LIANG Shang-Dong. Compounds of traditional Chinese medicine and neuropathic pain [J]. Chin J Nat Med, 2020, 18(1): 28-35.. doi: 10.1016/S1875-5364(20)30002-9

Compounds of traditional Chinese medicine and neuropathic pain

  • Abstract: Neuropathic pain (NP) has become a serious global health issue and a huge clinical challenge without available effective treatment. P2 receptors family is involved in pain transmission and represents a promising target for pharmacological intervention. Traditional Chinese medicine (TCM) contains multiple components which are effective in targeting different pathological mechanisms involved in NP. Different from traditional analgesics, which target a single pathway, TCMs take the advantage of multiple components and multiple targets, and can significantly improve the efficacy of treatment and contribute to the prediction of the risks of NP. Compounds of TCM acting at nucleotide P2 receptors in neurons and glial cells could be considered as a potential research direction for moderating neuropathic pain. This review summarized the recently published data and highlighted several TCMs that relieved NP by acting at P2 receptors.

     

/

返回文章
返回